American Pharmacists Association

APhA Former Board of Trustee Member Daniel Buffington named to the AMA's Current Procedural Terminology Editorial Panel

Retrieved on: 
Wednesday, February 19, 2020

WASHINGTON, Feb. 19, 2020 /PRNewswire/ -- The American Pharmacists Association (APhA) announced that former Board of Trustee member Daniel Buffington, PharmD, MBA, will be the first pharmacist to serve as a member of the American Medical Association's Current Procedural Terminology (CPT) Editorial Panel.

Key Points: 
  • WASHINGTON, Feb. 19, 2020 /PRNewswire/ -- The American Pharmacists Association (APhA) announced that former Board of Trustee member Daniel Buffington, PharmD, MBA, will be the first pharmacist to serve as a member of the American Medical Association's Current Procedural Terminology (CPT) Editorial Panel.
  • "It is truly an honor to represent pharmacists and the profession in this dynamic code development process," said Dr. Buffington.
  • "Pharmacists have developed a strong history of collaborative involvement and support from several of the leading national professional societies.
  • The CPT Editorial Panel ensures that CPT codes are up to date and support contemporary interdisciplinary practice models, clinical services, procedures, and diagnostic testing methods.

American Pharmacists Association Announces Recipients of 2020 Academy Awards

Retrieved on: 
Tuesday, January 28, 2020

WASHINGTON, Jan. 28, 2020 /PRNewswire/ --TheAmerican Pharmacists Association (APhA) today announced the selection of recipients of the APhA Academy of Pharmacy Practice & Management Awards, APhA Academy of Pharmaceutical Research & Science Awards, and APhA Academy of Student Pharmacist Awards as part of the 2020 APhA Awards and Honors Program.

Key Points: 
  • WASHINGTON, Jan. 28, 2020 /PRNewswire/ --TheAmerican Pharmacists Association (APhA) today announced the selection of recipients of the APhA Academy of Pharmacy Practice & Management Awards, APhA Academy of Pharmaceutical Research & Science Awards, and APhA Academy of Student Pharmacist Awards as part of the 2020 APhA Awards and Honors Program.
  • The American Pharmacists Association, founded in 1852 as the American Pharmaceutical Association, is a 501 (c)(6) organization, representing 60,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession.
  • APhA is dedicated to helping all pharmacists improve medication use and advance patient care and is the first and largest association of pharmacists in the United States.
  • https://www.pharmacist.com/apha-academy-pharmaceutical-research-and-science
    The APhA Academy of Student Pharmacists (APhAASP) represents student pharmacists at every school and college of pharmacy in the United States and Puerto Rico.

American Pharmacists Association Announces Recipients of 2020 Awards and Honors

Retrieved on: 
Thursday, January 23, 2020

WASHINGTON, Jan. 23, 2020 /PRNewswire/ --TheAmerican Pharmacists Association (APhA) today announced the selection of the 2020 Awards and Honors Program recipients.

Key Points: 
  • WASHINGTON, Jan. 23, 2020 /PRNewswire/ --TheAmerican Pharmacists Association (APhA) today announced the selection of the 2020 Awards and Honors Program recipients.
  • The APhA awards and honors program is the most comprehensive recognition program in the profession of pharmacy.
  • American Pharmacists Association Professionwide Awards:
    It was announced on January 14, 2020, that John D. Grabenstein of Easton, MD, is the recipient of the 2020 Remington Honor Medal, the highest honor in pharmacy that is bestowed by the American Pharmacists Association.
  • The American Pharmacists Association, founded in 1852 as the American Pharmaceutical Association, is a 501 (c)(6) organization, representing more than 62,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession.

John D. Grabenstein Receives Remington Honor Medal, Highest Honor in Pharmacy

Retrieved on: 
Tuesday, January 14, 2020

John D. Grabenstein, RPh, Ph.D.,of Easton, MD, is the recipient of the 2020 Remington Honor Medal, the highest honor bestowed by the American Pharmacists Association (APhA) and the profession's highest recognition.

Key Points: 
  • John D. Grabenstein, RPh, Ph.D.,of Easton, MD, is the recipient of the 2020 Remington Honor Medal, the highest honor bestowed by the American Pharmacists Association (APhA) and the profession's highest recognition.
  • Grabenstein, the first career military pharmacist to be recognized since the Remington Honor Medal's inception in 1919, recently retired as Global Executive Director of Medical Affairs for Merck Vaccines.
  • In 1996, Grabenstein wrote "Pharmacy-Based Immunization Delivery," APhA's certificate training program that has trained more than 340,000 pharmacists.
  • Dr. Grabenstein's nominators wrote that "despite all the accolades and accomplishments, John never hesitates to give back to the profession."

APhA Applauds Supreme Court's Decision to Rule on State Oversight of PBMs

Retrieved on: 
Saturday, January 11, 2020

WASHINGTON, Jan. 10, 2020 /PRNewswire/ --The American Pharmacists Association (APhA) applauds the U.S Supreme Court's decision to hear Rutledge v. Pharmaceutical Care Management Association, which addresses the State of Arkansas' regulation of pharmacy benefit managers (PBM).

Key Points: 
  • WASHINGTON, Jan. 10, 2020 /PRNewswire/ --The American Pharmacists Association (APhA) applauds the U.S Supreme Court's decision to hear Rutledge v. Pharmaceutical Care Management Association, which addresses the State of Arkansas' regulation of pharmacy benefit managers (PBM).
  • The Arkansas law is intended to provide fair access to generic drugs in Arkansas and transparency in PBM industry practices.
  • "We're pleased with the Supreme Court's decision to hear this case," said Ilisa Bernstein, PharmD, JD, FAPhA, APhA Senior Vice President, Pharmacy Practice and Government Affairs.
  • "State regulatory oversight plays an important role in curbing PBMs.

JFPS 2019: Sharing the vision in pharmacy

Retrieved on: 
Monday, October 7, 2019

WASHINGTON, Oct. 7, 2019 /PRNewswire/ -- The American Pharmacists Association (APhA) will host the 2019 Joint Federal Pharmacy Seminar (JFPS 2019) October 2730, 2019 in Dallas.

Key Points: 
  • WASHINGTON, Oct. 7, 2019 /PRNewswire/ -- The American Pharmacists Association (APhA) will host the 2019 Joint Federal Pharmacy Seminar (JFPS 2019) October 2730, 2019 in Dallas.
  • JFPS is the largest annual event for federal pharmacy.
  • Attendees learn and share solutions to challenges federal pharmacy professionals will face in today's health care systems.
  • The meeting offers Accreditation Council for Pharmacy Education (ACPE)certified continuing pharmacy education (CPE) and training programs, which are provided by APhA.

APhA Issues Statement on John Oliver's September 29 Segment on Compounding Pharmacies

Retrieved on: 
Tuesday, October 1, 2019

These included that "compounding pharmacists play an important role in patient care" and "lots of people need compounding drugs."

Key Points: 
  • These included that "compounding pharmacists play an important role in patient care" and "lots of people need compounding drugs."
  • Compounding is the practice of pharmacy with an emphasis on preparing customized dosage forms and/or prescription medications to meet an individual patient's or physician's needs.
  • The segment correctly states that Congress appropriately passed federal legislation, the Drug Quality and Security Act (DQSA), signed into law by President Obama in 2013, to regulate compounding.
  • APhA was pleased Congress passed a federal law to regulate compounding.

APhA Opens Search for Executive Vice President and Chief Executive Officer

Retrieved on: 
Wednesday, September 18, 2019

WASHINGTON, Sept. 18, 2019 /PRNewswire/ --The American Pharmacists Association (APhA) has launched a search for the Association's next Executive Vice President and Chief Executive Officer.

Key Points: 
  • WASHINGTON, Sept. 18, 2019 /PRNewswire/ --The American Pharmacists Association (APhA) has launched a search for the Association's next Executive Vice President and Chief Executive Officer.
  • Earlier this year, EVP/CEO Thomas E. Menighan, BPharm, MBA, ScD (Hon), announced his retirement, effective at midyear 2020.
  • The Executive Vice President and Chief Executive Officer is the chief staff executive of APhA and reports directly to the Association's Board of Trustees.
  • S/he leads the direction of operations and activities of APhA, including the APhA Foundation and the Board of Pharmacy Specialties, and 2200 C Street LLC.

Rapid Dose Therapeutics Completes Quickstrip™ Equipment Installation at Aphria Inc.

Retrieved on: 
Tuesday, September 10, 2019

BURLINGTON, Ontario, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (RDT) ( CSE: DOSE ) announced today that the installation and commissioning of its QuickStrip production equipment at Aphria Inc. (Aphria) (TSX: APHA and NYSE: APHA) has been completed pursuant to the terms of the Managed Strip Services Agreement between RDT and Aphria dated November 1, 2018 (the Agreement).

Key Points: 
  • BURLINGTON, Ontario, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (RDT) ( CSE: DOSE ) announced today that the installation and commissioning of its QuickStrip production equipment at Aphria Inc. (Aphria) (TSX: APHA and NYSE: APHA) has been completed pursuant to the terms of the Managed Strip Services Agreement between RDT and Aphria dated November 1, 2018 (the Agreement).
  • In light of the installation of RDT QuickStrip production equipment, Aphria will now move forward with its production and distribution planning in Canada.
  • Aphria is excited to introduce RDTs QuickStrip products to the Canadian cannabis market later this year, said Irwin D. Simon, Interim CEO, Aphria Inc.
  • Rapid Dose Therapeutics is committed to continually create innovative solutions aimed at multiple consumer segments and future market needs including humans, animals and plants.

APhA names Ilisa Bernstein senior vice president, pharmacy practice and government affairs

Retrieved on: 
Tuesday, September 3, 2019

WASHINGTON, Sept. 3, 2019 /PRNewswire/ --The American Pharmacists Association (APhA) has named Ilisa Bernstein, PharmD, JD, FAPhA, as its new Senior Vice President of Pharmacy Practice and Government Affairs, effective October 14.

Key Points: 
  • WASHINGTON, Sept. 3, 2019 /PRNewswire/ --The American Pharmacists Association (APhA) has named Ilisa Bernstein, PharmD, JD, FAPhA, as its new Senior Vice President of Pharmacy Practice and Government Affairs, effective October 14.
  • Bernstein will be responsible for leading implementation of the association's strategies related to professional affairs, pharmacy practice, advocacy, and government affairs.
  • Bernstein has over 30 years of experience advocating for pharmacy and patients at the U.S. Food and Drug Administration (FDA), where she has held several senior leadership positions.
  • Bernstein has also been director of pharmacy affairs for FDA and senior advisor for regulatory policy in the Office of the Commissioner.